3 Results for "

Gi coupling

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Gi coupling" in MCE Product Catalog:

Cat. No.: HY-171978
Target:  

Adrenergic Receptor

Research Areas:  

Cardiovascular Disease

LM-189 is a β2-adrenergic receptor (β2AR) ligand and G protein-biased modulator with a human β2AR Ki of 0.063 nM.LM-189 promotes β2AR coupling to Gαs and Gαi heterotrimers, stabilizes distinct β2AR conformations including a TM6 outward state, and increases β2AR ICL2 dynamics.LM-189 restricts β2AR ligand-binding pocket conformational heterogeneity, stabilizes polar ligand-receptor interaction networks, and exhibits bias toward Gαi signaling over Gαs signaling.LM-189 enabled cryo-EM structural characterization of the β2AR-Gi complex.LM-189 can be used for the research of congestive heart failure .
loading...
    loading...
Cat. No.: HY-121140
CAS No.: 2016864-46-1
Purity:  99.8%
Research Areas:  

Metabolic Disease

AZ1729 is an FFA2/FFAR2 allosteric modulator and Gi-biased signaling enhancer. AZ1729 binds to the FFA2 allosteric site without interacting with the orthosteric site, enhances Gi coupling, and inhibits Gq/G11 coupling. AZ1729 inhibits Isoprenaline (HY-B0468)-induced lipolysis in mouse adipocytes. AZ1729 also induces human neutrophil migration. AZ1729 can be used to study the signaling pathways underlying the physiological roles of FFA2 .
loading...
    loading...
Cat. No.: HY-174335
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

UVI3502 is a cannabinoid receptor 1 (CB1) antagonist with an IC50 value of 4641 nM for CB1 and approximately 16200 nM for CB2. UVI3502 blocks Gi/o protein coupling induced by the agonist CP55,940. UVI3502 is promising for research of endocannabinoid system-related diseases in the central nervous system (such as cognitive impairment and neurodegenerative diseases) .
loading...
    loading...